Stocking injectables and skincare without tying up your cash

Injectables and professional skincare are two of the most expensive line items on a med spa’s balance sheet, and both can quietly tie up cash if purchasing is not tracked as carefully as the treatments themselves. Neurotoxin and filler have real shelf lives once reconstituted or opened, and skincare inventory that sits on a shelf for a year is capital that should have been working somewhere else. Getting purchasing terms and inventory discipline right protects margin on both ends.

Buy on volume tiers, not habit

Most injectable manufacturers and their authorized distributors offer tiered pricing based on annual or quarterly purchase volume, and practices that order reactively, restocking only when they run low, often miss the threshold for a better tier by a small margin. Track your trailing twelve-month purchase volume by product and compare it against the next pricing tier before your next order; sometimes a slightly larger order timed correctly pays for itself in the discount alone.

Loyalty and rewards programs run by the major manufacturers can also apply to purchasing, not just to client-facing promotions, and stacking practice-level purchasing rewards with client loyalty points is worth confirming with your rep rather than assuming they are separate and unrelated.

Match order size to actual usage, not the sales rep’s suggestion

Order quantities recommended by a distributor rep are built around moving product, not around your specific patient volume. Build your own reorder point based on your actual weekly or monthly usage per product, with a safety buffer sized to your realistic delivery lead time. Overordering neurotoxin or filler ties up cash and risks product expiring unused, while underordering means turning away bookable revenue when a popular product runs out mid-week.

Skincare retail inventory has a different problem: it is easy to overbuy a full product line when a new brand launches, only to discover three SKUs move quickly and the rest sit for months. Track sell-through by SKU, not just by brand, and be willing to discontinue slow movers rather than holding shelf space and cash hostage to a line that is not resonating with your clients.

Verify authorized distribution channels

Only purchase injectables through the manufacturer’s authorized distribution channel for your region. Gray-market or diverted product is a genuine patient safety risk, since storage and handling cannot be verified, and it can also void any manufacturer support or complication coverage tied to the product. If a deal on filler or neurotoxin looks meaningfully better than your usual authorized rep can offer, verify the seller’s authorization status directly with the manufacturer before purchasing, not after. Our directory lists authorized suppliers and manufacturer contacts by category.

Storage and cold chain discipline

Neurotoxin and many fillers require specific storage conditions, and a single refrigerator failure or a delivery left on a doorstep in summer heat can destroy an entire order’s worth of product. Log temperature checks on any refrigerated storage and have a documented protocol for what happens if cold chain is broken during delivery, including who to call at the distributor. This is both a financial protection and part of the clinical documentation a compliance review would expect to see; pair this with the cost-per-unit pricing approach in our guide on pricing treatments and memberships so waste from storage failures is factored into your margin, not absorbed silently.